These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17362590)

  • 1. Cross-reactivity of Actrapid and three insulin analogues in the Abbott IMx insulin immunoassay.
    Song D; Davidson J
    Ann Clin Biochem; 2007 Mar; 44(Pt 2):197-8. PubMed ID: 17362590
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-reactivity of 12 recombinant insulin preparations in the Beckman Unicel DxI 800 insulin assay.
    Glenn C; Armston A
    Ann Clin Biochem; 2010 May; 47(Pt 3):264-6. PubMed ID: 20392753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Importance of the structure of insulin preparations for clinical practice].
    Svacina S
    Vnitr Lek; 2009 Apr; 55(4):409-11. PubMed ID: 19449759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elecsys insulin assay: free insulin determination and the absence of cross-reactivity with insulin lispro.
    Sapin R; Le Galudec V; Gasser F; Pinget M; Grucker D
    Clin Chem; 2001 Mar; 47(3):602-5. PubMed ID: 11238323
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of an Abbott ARCHITECT cyclosporine immunoassay without metabolite cross-reactivity.
    Brate EM; Finley DM; Grote J; Holets-McCormack S; Ozaeta PF; Pacenti D; Peart JE; Piktel RE; Ramsay CS; Rupprecht KR; Saldana SC; Spring TG; Tetin SY; Trudeau BC; Wang P; Xie H
    Clin Biochem; 2010 Sep; 43(13-14):1152-7. PubMed ID: 20599875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for interference in immunoassays.
    Span PN; Grebenchtchikov N; Geurts-Moespot J; Sweep CG
    Clin Chem; 2003 Oct; 49(10):1708-9. PubMed ID: 14500605
    [No Abstract]   [Full Text] [Related]  

  • 7. Most commercial insulin assays fail to detect recombinant insulin analogues.
    Heald AH; Bhattacharya B; Cooper H; Ullah A; McCulloch A; Smellie S; Wark G
    Ann Clin Biochem; 2006 Jul; 43(Pt 4):306-8. PubMed ID: 16824282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous interference in immunoassays in clinical chemistry. A review.
    Weber TH; Käpyaho KI; Tanner P
    Scand J Clin Lab Invest Suppl; 1990; 201():77-82. PubMed ID: 2244186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin formulations].
    Lill N
    Pharm Unserer Zeit; 2001 Jan; 30(1):56-62. PubMed ID: 11233184
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross-reactivity of new insulin analogs in insulin assays.
    Vieira JG; Tachibana TT; Ferrer CM; Reis AF
    Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):504-5. PubMed ID: 17546253
    [No Abstract]   [Full Text] [Related]  

  • 11. Extensive study of human insulin immunoassays: promises and pitfalls for insulin analogue detection and quantification.
    Heurtault B; Reix N; Meyer N; Gasser F; Wendling MJ; Ratomponirina C; Jeandidier N; Sapin R; Agin A
    Clin Chem Lab Med; 2014 Mar; 52(3):355-62. PubMed ID: 24150210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivity of insulin analogs with the Diasorin Liaison insulin assay.
    Gruson D; Maisin D; Preumont V; Vandeleene B
    Clin Chem Lab Med; 2011 Jun; 49(6):1081-2. PubMed ID: 21410416
    [No Abstract]   [Full Text] [Related]  

  • 13. IMx (Abbott) Immunoassay of Insulin: A Practical Alternative to RIA Hyperinsulinemia Identification in Idiopathic Neurootology and Other Hyperinsulin Metabolic Disorders.
    Kraft JR
    Int Tinnitus J; 1997; 3(2):113-116. PubMed ID: 10753372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance characteristics of a no-pretreatment, random access sirolimus assay for the Dimension RxL clinical chemistry system.
    Cervinski MA; Duh SH; Hock KG; Gray J; Wei TQ; Kilgore DC; Christenson RH; Scott MG
    Clin Biochem; 2009 Jul; 42(10-11):1123-7. PubMed ID: 19303402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin analogues: a step forward in the care in diabetes.
    Holt RI
    Diabetes Obes Metab; 2009 Jan; 11(1):1-4. PubMed ID: 19120430
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical therapeutics. Realising the value of modern insulins: reaching further with rapid-acting insulin analogues. XIX World Diabetes Congress, Cape Town, South Africa, December 3, 2006. Forward.
    Heise T
    Clin Ther; 2007; 29 Suppl D():S133-4. PubMed ID: 18504874
    [No Abstract]   [Full Text] [Related]  

  • 17. Rheumatoid factor can interfere with cystatin C measurement.
    Lamb E; Stowe H
    Ann Clin Biochem; 2003 Mar; 40(Pt 2):195-6. PubMed ID: 12666666
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA
    Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USAN Council. List No.417. New names. Insulin Aspart.
    Clin Pharmacol Ther; 1999 Jul; 66(1):103. PubMed ID: 10447384
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin analogues in the treatment of diabetes in pregnancy.
    Singh C; Jovanovic L
    Obstet Gynecol Clin North Am; 2007 Jun; 34(2):275-91, ix. PubMed ID: 17572272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.